Detalles de la búsqueda
1.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
2.
Evaluating the economic burden of acute myeloid leukemia in Canada.
Acta Haematol
; 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382483
3.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol
; 203(5): 781-791, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697469
4.
Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections.
Transpl Infect Dis
; 25 Suppl 1: e14101, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461887
5.
BCR-ABL1 transcript doubling time as a predictor for treatment-free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
Br J Haematol
; 196(1): 136-145, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34496035
6.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica
; 107(5): 1045-1053, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382386
7.
Optimal duration of imatinib treatment/deep molecular response for treatment-free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
Br J Haematol
; 193(4): 779-791, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33876423
8.
Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia.
Pediatr Blood Cancer
; 67(7): e28263, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32323913
9.
Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 25(10): 2086-2090, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228584
10.
Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis.
Biol Blood Marrow Transplant
; 25(6): 1172-1178, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30769192
11.
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Am J Hematol
; 91(3): 322-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26701142
12.
Routine filtration of hematopoietic stem cell products: the time has arrived.
Transfusion
; 55(8): 1980-4, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25988869
13.
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.
Biol Blood Marrow Transplant
; 20(2): 202-8, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24184335
14.
Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.
Br J Haematol
; 166(5): 660-6, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24780059
15.
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Curr Oncol
; 31(3): 1426-1444, 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534941
16.
Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting.
Blood
; 118(25): 6698-701, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22039259
17.
The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety.
Curr Oncol
; 30(3): 3549-3556, 2023 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36975483
18.
Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.
Curr Oncol
; 30(11): 9953-9967, 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37999143
19.
Access to Hematopoietic Stem Cell Transplant in Canada for Patients with Acute Myeloid Leukemia.
Curr Oncol
; 29(8): 5198-5208, 2022 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35892981
20.
Real-World Treatment Patterns and Clinical Outcomes in Canadian Patients with AML Unfit for First-Line Intensive Chemotherapy.
Curr Oncol
; 29(10): 6794-6806, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36290812